Supernus Pharmaceuticals SUPN Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's quick ratio?
- Supernus Pharmaceuticals (SUPN) reported quick ratio of 1.9× in Q1 2026.
- How has Supernus Pharmaceuticals's quick ratio changed year-over-year?
- Supernus Pharmaceuticals's quick ratio decreased by 16.4% year-over-year, from 2.3× to 1.9×.
- What is the long-term trend for Supernus Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's quick ratio has grown at a -5.2% compound annual growth rate (CAGR), from 2.4× to 1.8×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.